SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Deshaies Robert Joseph (Last) (First) (Middle) C/O WEX INC., 97 DARLING AVENUE (Street) SOUTH PORTLAND ME 04106 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 09/10/2019	3. Issuer Name and Ticker or Trading Symbol WEX Inc. [ WEX ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) President, WEX Health	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	5,956	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	(1)	Common Stock	96	$0.0	D
Restricted Stock Units	(2)	(2)	Common Stock	127	$0.0	D
Restricted Stock Units	(3)	(3)	Common Stock	190	$0.0	D
Stock Option (right to buy)	03/15/2017	03/15/2026	Common Stock	1,032	$77.2	D
Stock Option (right to buy)	03/20/2018(4)	03/20/2027	Common Stock	843	$104.95	D
Stock Option (right to buy)	03/15/2019(5)	03/15/2018	Common Stock	585	$158.23	D
Stock Option (right to buy)	03/20/2020(6)	03/20/2029	Common Stock	601	$184.81	D

Explanation of Responses:

1. RSUs vest with respect to the entirety of these units on March 20, 2020.

2. RSUs vest with respect to half of these units on March 15, 2020 and March 15, 2021.

3. RSUs vest with respect one third of these units on March 20, 2020, March 20, 2021, and March 20, 2022.

4. The option became exercisable as to 280 shares on March 20, 2018, 281 shares on March 20, 2019, and becomes exercisable as to the remaining 282 shares on March 20, 2020.

5. The option became exercisable as to 194 shares on March 15, 2019, and becomes exercisable as to 195 shares on March 20, 2020 and 196 shares on March 20, 2021.

6. The option becomes exercisable with respect to 200 shares on March 20, 2020, 200 shares on March 20, 2021, and 201 shares on March 20, 2022.

Remarks:

EXHIBIT LIST: EX-24 Power of Attorney Robert Deshaies

	/s/ Gregory Wiessner, as attorney-in-fact for Robert Joseph Deshaies	09/18/2019
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.